Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Lucija Peterlin Mašič

PhD Lucija Peterlin Mašič
no.: 19317 source: ARIS

researcher – active in research organisation
lucija.peterlinat signffa.uni-lj.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • German
  • Reading: Functional
  • Writing: Functional
  • Speaking: Functional
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
3.07.00  Medical sciences  Metabolic and hormonal disorders   
Keywords
Medicinal chemistry, instrumental pharmaceutical analysis, thrombne inhibitors, combinatorial chemistry, synthesis, blood coagulation
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
923.51
A''
154.71
A'
497.93
A1/2
600.16
CI10
2,698
CImax
198
h10
30
A1
3.29
A3
0.32
Data for the last 5 years (citations for the last 10 years) on April 27, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 105  3,217  2,755  26.24 
Scopus 110  3,551  3,038  27.62 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Martina Durcik  Bologna doctoral studies  10/1/2018 - 9/30/2023  50490 
2 PhD Darja Gramec Skledar  Bologna doctoral studies  12/1/2012 - 10/31/2018  35432 
3 PhD Anja Fic  Bologna doctoral studies  11/1/2010 - 7/3/2014  33295 
4 PhD Tihomir Tomašić  Uniform doctoral studies  11/1/2006 - 4/30/2011  28334 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.   Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 1998 
Doctor's degree      SI 2003 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position ecris.org.employ_rolegroup Title
Full time employment (120%, RD:30%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  11/1/1998    Researcher  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J1-50023  3DfluorCO - Three-dimensional fluorine-based carbonyl bioisosteres: asymmetric synthesis and validation   2023 - 2024  PhD Andrej Emanuel Cotman  1,047 
2. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,052 
3. BI-DE/23-24-009  New mitochondrial ion channels Kv1.3 inhibitors as inducers of apoptosis   2023 - 2024  PhD Lucija Peterlin Mašič  407 
4. J1-3031  Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance   2021 - 2024  PhD Nace Zidar  1,033 
5. J1-3030  MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance   2021 - 2024  PhD Lucija Peterlin Mašič  956 
6. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour   2021 - 2024    4,836 
7. N1-0172  Fotokemijski pristop za odkrivanje naprednih ATP-kompetitivnih prob z zaviralnim delovanjem na Topoizomerazo IIalfa (Slovene)   2021 - 2023  PhD Janez Ilaš  739 
8. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity   2019 - 2023  PhD Tihomir Tomašić  1,894 
9. N1-0098  Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity   2019 - 2022  PhD Lucija Peterlin Mašič  885 
10. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   2018 - 2021  PhD Lucija Peterlin Mašič  2,197 
11. J1-8140  Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard in zdravje ljudi   2017 - 2020  PhD Metka Filipič  3,739 
12. V3-1636  New psychoactive substances monitoring system in Slovenia (acronym SONDA)   2016 - 2018  PhD Miran Brvar  1,490 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2022 - 2024  PhD Stanislav Gobec  5,315 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2015 - 2021  PhD Stanislav Gobec  5,977 
3. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)   2009 - 2014  PhD Danijel Kikelj  5,850 
4. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)   2004 - 2008  PhD Danijel Kikelj  6,007 
5. P0-0502-0787  Farmacevtska kemija (Slovene)   2001 - 2003  PhD Danijel Kikelj  7,526 
International projects
no. Code Title Period Head
1. CELSA - Cental Europe Leuven Strategic Alliance-Discovery  Discovery of new leads modulating voltage gated potassium ion channels as emerging cancer targets   1/1/2017 - 12/31/2018  Lucija Peterlin Mašič   
2. COST-CM1307  Targeted chemotherapy towards diseases caused by endoparasites   3/12/2014 - 3/11/2018     
3. COST-CM0801  New drugs for neglected diseases   11/28/2008 - 11/27/2012  Lucija Peterlin Mašič   
Confirmation required
Views history
Favourite